Muscarinic receptor subtype determines vulnerability to amyloid β toxicity in transfected cos-7 cells

Journal of Alzheimer's Disease

Volumn 5, Issue 3, 2003, Pages 197-208

  Joseph, J A ^a   Fisher, D R ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; DOPAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; NIFEDIPINE; OXOTREMORINE;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CARDIOVASCULAR SYSTEM; CELL VIABILITY; CONTROLLED STUDY; DEPOLARIZATION; GENETIC TRANSFECTION; IMAGE ANALYSIS; MICROCIRCULATION; MULTIINFARCT DEMENTIA; NERVE FUNCTION; NERVE POTENTIAL; NERVOUS SYSTEM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; RECEPTOR SENSITIVITY;

EID: 0142042436     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2003-5304     Document Type: Article

References (72)

1. G. Azhar, L. Liu, X. Zhang and J.Y. Wei, Influence of age on hypoxia/reoxygenation-induced DNA fragmentation and bcl-2, bcl-xl, bax and fas in the rat heart and brain, Mechanisms of Ageing and Development 112 (1999), 5-25.
2. M.F. Beal, Oxidative metabolism, Annals of the New York Academy of Science 924 (2000), 164-169.
3. L.T. Bonner and E.R. Peskind, Pharmacologic treatments of dementia, The Medical clinics of North America 86 (2002), 57-74.
4. T.I. Bonner, A.C. Young, M.R. Brann and N.J. Buckley, Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes, Neuron 1 (1988), 403-410.
5. T.I. Bonner, N.J. Buckley, A.C. Young and M.R. Brann, Identification of a family of muscarinic acetylcholine receptor genes, Science 237 (1987), 527-532.
6. J.M. Carney, Oxidative stress leading to loss of critical proteases in Alzheimer's disease. An alternative view of the etiology of AD, Annals of the New York Academy of Science 924 (2000), 160-163.
7. 2+-induced cytotoxicity in PC-12 cells, Journal of Neurochemistry 66 (1994), 895-902.
8. M.R. Cookson, N.M. Thatcher, P.G. Ince and P.J. Shaw, Selective loss of neurofilament proteins after exposure of differentiated human IMR-32 neuroblastoma cells to oxidative stress, Brain Research 738 (1996), 162-166.
9. R. Cutler, J.A. Joseph, K. Yamagami, R. Villalobos-Molina and G.S. Roth, Alterations in muscarinic stimulated low KM GTPase activity in aging and Alzheimer's disease: Implications for impaired signal transduction, Brain Research 664 (1994), 54-60.
10. R. Dawson, M.F. Beal, S.C. Bondy, D.A. Di Monte and G.E. Isom, Excitotoxins, aging, and environmental neurotoxins: Implications for understanding human neurodegenerative diseases, Toxicology and Applied Pharmacology 134 (1995), 1-17.
11. V. Deschamps, P. Barberger-Gatea, E. Peuchant and J.M. Orgogozo, Nutritional factors in cerebral aging and dementia: epidemiological arguments for a role of oxidative stress, Neuroepidemiology 20 (2001), 7-15.
12. T. Egashira, F. Takayama and Y. Yamanaka, Effects of bifemelane on muscarinic receptors and choline acetyltransferase in the brains of aged rats following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries, Japanese Journal of Pharmacology 72 (1996), 57-65.
13. A. Elhusseiny, Z. Cohen, A. Olivier, D.B. Stanimirovic and E. Hamel, Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization, Journal of Cerebral Blood Flow and Metabolism 19 (1999), 794-802.
14. 3 muscarinic receptor subtypes in primate brain, Synapse 14 (1993), 283-296.
15. T.C. Foster and A. Kumar, Calcium dysregulation in the aging brain, Neuroscientist 8 (2002), 297-301.
16. E.P. Gilissen, R.E. Jacobs and J.M. Allman, Magnetic resonance microscopy of iron in the basal forebrain cholinergic structures of the aged mouse lemur, Journal of Neurological Science 168 (1999), 21-27.
17. C.L. Grady and F.I. Craik, Changes in memory processing with age, Current Opinion in Neurobiology 10 (2000), 224-231.
18. 2+ indicators with greatly improved fluorescence properties, Journal of Biological Chemistry 260 (1985), 3440-3450.
19. H. Hartmann, K. Velbinger, A. Eckert and W.E. Muller, Region-specific downregulation of free intracellular calcium in the aged rat brain, Neurobiology of Aging 17 (1996), 557-563.
20. 2: Calcium-dependent activation of the EGF receptor/ERK pathway, Journal of Biological Chemistry (submitted).
21. B. Hauss-Wegrzyniak, P. Vraniak and G.L. Wenk, The effects of a novel NSAID on chronic neuroinflammation are age dependent, Neurobiology of Aging 20 (1999), 305-313.
22. L.M. He, L.Y. Chen, X.L. Lou, A.L. Qu, Z. Zhou and T. Xu, Evaluation of beta-amyloid peptide 25-35 on calcium homeostasis in cultured rat dorsal root ganglion neurons, Brain Research 7 (2002), 65-75.
23. M.A. Hebert and G.A. Gerhardt, Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: an in vivo electrochemical study, Journal of Pharmacology and Experimental Therapeutics 288 (1999), 879-887.
24. S.M. Hersch, C.A. Gutekunst, H.D. Rees, C.J. Heilman and A.I. Levey, Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies, Journal of Neuroscience 5 (1994), 3351-3363.
25. R. Ho, D. Ortiz and T.B. Shea, Amyloid-beta promotes calcium flux and neurodegeneration via stimulation of L-voltage-sensitive calcium channels rather than NMDA channels in cultured neurons, Journal of Alzheimer's Disease 3 (2001), 479-483.
26. H.M. Huang, H.C. Ou and S.J. Hsieh, Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons, Life Sciences 31 (2000), 1879-1892.
27. D.K. Ingram, E.L. Spangler, S. Iijima, H. Ikari, H. Kuo, N.H. Greig and E.D. London, Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis, Life Sciences 55 (1994), 2037-2049.
28. J.A. Joseph, D.R. Fisher and J. Strain, Muscarinic receptor subtype determines vulnerability to oxidative stress in COS-7 cells, Free Radical Biology and Medicine 32 (2002), 153-161.
29. J.A. Joseph, B. Shukitt-Hale, N.A. Denisova, A. Martin, G. Perry and M.A. Smith, Copernicus revisited: amyloid beta in Alzheimer disease, Neurobiology of Aging 22 (2001), 131-146.
30. J.A. Joseph, S. Erat, N.A. Denisova and R. Villalobos-Molina, Receptor- and age-selective effects of dopamine oxidation on receptor-G protein interactions in the striatum, Free Radical Biology and Medicine 24 (1998), 827-834.
31. J.A. Joseph, N. Denisova, D, Fisher, B. Shukitt-Hale, P. Bickford, R. Prior and G. Cao, Membrane and receptor modifications of oxidative stress vulnerability in aging. Nutritional considerations, Annals of the New York Academy of Science 854 (1998), 268-276.
32. J.A. Joseph, J. Strain and N.D. Jimenez, Oxidant injury in PC-12 cells: A possible model of calcium "dysregulation" in aging I: Selectivity of antioxidant protection, Journal of Neurochemistry 69 (1997), 1252-1258.
33. 2-or NO-induced reductions in K+-evoked dopamine release from superfused striatal slices: Reversals by PBN or Trolox, Free Radical Biology and Medicine 20 (1996), 821-830.
34. J.A. Joseph, M.A. Kowatch, T Maki and G.S. Roth, Selective cross activation/inhibition of second messenger systems and the reduction of age-related deficits in the muscarinic control of dopamine release from perifused rat striata, Brain Research 537 (1990), 40-48.
35. J.A. Joseph, T.K. Dalton, G.S. Roth and W.A. Hunt, Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: A deficit at the ligand-muscarinic receptor interface? Brain Research 454 (1988), 149-155.
36. +-evoked release of endogenous striatal dopamine. An indicator of altered cholinergic-Dopaminergic reciprocal inhibitory control in senescence, Brain Research 454 (1988), 140-148.
37. J.A. Joseph, R.E. Berger, B.T. Engel and G.S. Roth, Age-related changes in the nigrostriatum: A behavioral and biochemical analysis, Journal of Gerontology 33 (1978), 643-649.
38. V. Kaasinen, H. Vilkman, J. Hietala, K. Nagren, H. Helenius, H. Olsson, L. Farde and J. Rinne, Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain, Neurobiology of Aging 21 (2000), 683-688.
39. J. Kasparova, V. Lisa, S. Tucek and V. Dolezal, Chronic exposure of NG108-15 cells to amyloid beta peptide (A beta (1-42)) abolishes calcium influx via N-type calcium channels, Neurochemical Research 26 (2001), 1079-1084.
40. J.A. Kaufmann, P.C. Bickford and G. Taglialatela, Oxidative-stress-dependent up-regulation of Bcl-2 expression in the central nervous system of aged Fisher-344 rats, Journal of Neurochemistry 76 (2001), 1099-1108.
41. T. Koga and J. Terao, Antioxidant behaviors of vitamin E analogues in unilamellar vesicles, Bioscience, Biotechnology, and Biochemistry 60 (1996), 1043-1045.
42. M.J. LaVoie and T.G. Hastings, Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine, Journal of Neuroscience 19 (1999), 1484-1491.
43. A.I. Levey, Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease, Proceedings of the National Academy of Sciences of the United States of America 93 (1996), 13541-13546.
44. M.S. Levine and C. Cepeda, Dopamine modulation of responses mediated by excitatory amino acids in the neostriatum, Advances in Pharmacology 42 (1998), 724-729.
45. D.R. Lynch and TM. Dawson, Secondary mechanisms in neuronal trauma, Current Opinion in Neurology 7 (1994), 510-516.
46. M. Michikawa, Q.W. Fan, I. Isobe and K. Yanagisawa, Apolipoprotein E exhibits isoform-specific promotion of efflux from astrocytes and neurons in culture, Journal of Neurochemistry 74 (2000), 1008-1016.
47. J.C. Morris, The nosology of dementia, Neurologic Clinics 18 (2000), 773-788.
48. P.D. Mozley, P.D. Acton, E.D. Barraclough, K. Plossl, R.C. Gur, A. Alavi, A. Mathur, J. Saffer and H.F. Kung, Effects of age on dopamine transporters in healthy humans, Journal of Nuclear Medicine 40 (1999), 1812-1817.
49. C. O'Neill, R.F. Cowburn, W.L. Bonkale, T.G. Ohm, J. Fastbom, M. Carmody and M. Kelliher, Dysfunctional intracellular calcium homeostasis: a central cause of neurodegeneration in Alzheimer Disease, Biochemical Society Symposium 67 (2001), 177-194.
50. K. Pahlmark and B.K. Siesjo, Effects of the spin trap-alphaphenyl-N-tert-butyl nitrone (PBN) in transient forebrain ischaemia in the rat, Acta Physiologica Scandinavica 157 (1996), 41-51.
51. M.C. Papadopoulos, I.L. Koumenis, T.Y. Yuan and R.G. Giffard, Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses, Neuroscience 82 (1998), 915-925.
52. M.A. Piggott, E.F. Marshall, N. Thomas, S. Lloyd, J.A. Court, E. Jaros, D. Burn, M. Johnson, R.H. Perry I.G. McKeith, C. Ballard and E.K. Perry, Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution, Brain 122 (1999), 1449-1468.
53. C.J. Pike, N. Ramezan-Arab and C.W. Cotman, Beta-amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants, Journal of Neurochemistry 69 (1997), 1601-1611.
54. S. Rossner, U. Ueberham, R. Schliebs, J.R. Perez-Polo and V. Bigl, The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling, Progress in Neurobiology 56 (1998), 541-569.
55. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider and L.J. Thal, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, The New England Journal of Medicine 336 (1997), 1216-1222.
56. J. Savory, J.K. Rao, Y. Huang, P.R. Letada and M.M. Herman, Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging, Neurotoxicology 20 (1999), 805-817.
57. B. Shukitt-Hale, The effects of aging and oxidative stress on psychomotor and cognitive behavior, Age 22 (1999), 9-17.
58. B. Shukitt-Hale, G. Mouzakis and J.A. Joseph, Psychomotor and spatial memory performance in aging male Fischer 344 rats, Experimental Gerontology 33 (1998), 615-624.
59. B.K. Siesjo, E. Elmer, J. Janelidze, M. Keep, T. Kristian, Y.B. Ouyang and H. Uchino, Role and mechanisms of secondary mitochondrial failure, Acta Neurochirurgica. Supplement (Wien) 73 (1999), 7-13.
60. M.A. Smith, A. Nunomura, X. Zhu, A. Takeda and G. Perry, Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease, Antioxidants and Redox Signalling 2 (2000), 413-420.
61. M.A. Smith, K. Hirai, K. Hsiao, M.A. Pappolla, P.L. Harris, S.L. Siedlak, M. Tabaton and G. Perry, Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress, Journal of Neurochemistry 70 (1998), 2212-2215.
62. M.A. Smith, M. Rudnicka-Nawrot, P.L. Richey, D. Praprotnik, P. Mulvihill, C.A. Miller, L.M. Sayre and G. Perry, Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease, Journal of Neurochemistry 64 (1995), 2660-2666.
63. A. Stocker and A. Azzi, Tocopherol-binding proteins: their function and physiological significance, Antioxidants and Redox Signalling 2 (2000), 397-404.
64. R. Strong, Neurochemical changes in the aging human brain: implications for behavioral impairment and neurodegenerative disease, Geriatrics 53 (1998), S9-S12.
65. N.C. Sturgess, A. Rustad, F. Fonnum and E.A. Lock, Neurotoxic effect of L-2-chloropropionic acid on primary cultures of rat cerebellar granule cells, Archives of Toxicology 74 (2000), 153-160.
66. N.V. Uboga and J.L. Price, Formation of diffuse and fibrillar tangles in aging and early Alzheimer's disease, Neurobiology of Aging 21 (2000), 1-10.
67. N.D. Volkow, G.J. Wang, J.S. Fowler, Y.S. Ding, R.C. Gur, J. Gatley, J. Logan, P.J. Moberg, R. Hitzemann, G. Smith and N. Pappas, Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging, Annals of Neurology 44 (1998), 143-147.
68. J. Wess, T.I. Bonner and M. Brann, Chimeric m2/m3 muscarinic receptors: Role of Carboxyl Terminal Receptor Domains in Selectivity oh Ligand Binding Coupling to Phosphoinositide Hydrolysis, Molecular Pharmacology 38 (1990), 872-877.
69. N.J. Willmott, K. Wong and A.J. Strong, A fundamental role for the nitric oxide-G-kinase signaling pathway in mediating intercellular Ca(2+) waves in glia, Journal of Neuroscience 20 (2000), 1767-1779.
70. D.S. Wolf, M. Gearing, D.A. Snowdon, H. Mori, W.R. Markesbery and S.S. Mirra, Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study, Alzheimer Disease and Associated Disorders 13 (1999), 226-231.
71. K. Yamagami, J.A. Joseph and G.S. Roth, Decrement in muscarinic-receptor stimulated low KM GTPase in striata and hippocampus from aged rat, Brain Research 576 (1992), 327-331.
72. F. Yufu, T. Egashira and Y. Yamanaka, Age-related changes of cholinergic markers in the rat brain, Japanese Journal of Pharmacology 66 (1994), 247-255.